|
|
BSE |
NSE |
|
|
Products & Services > Company Profile > Profit & Loss |
|
| Strides Pharma Science Ltd | Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln | BSE Code: | 532531 | | NSE Symbol: | STAR | | P/E : | 92.7 | ISIN Demat: | INE939A01011 | | Div & Yield %: | 0.17 | | EPS : | 9.53 | Book Value: | 376.844232 | | Market Cap (Rs.Cr): | 8118.88 | | Face Value : | 10 | |
|
(Rs. In Crores) |
|
| | | | | | Sales Turnover | 1854.50 | 1979.00 | 1857.57 | 1691.93 | 1537.44 | 1469.61 | Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Net Sales | 1854.50 | 1979.00 | 1857.57 | 1691.93 | 1537.44 | 1469.61 | Other Income | 84.07 | 123.49 | 117.09 | 93.07 | 114.61 | 894.95 | Stock Adjustments | -21.04 | -114.26 | 117.53 | 2.88 | 45.52 | 17.79 | Total Income | 1917.53 | 1988.23 | 2092.19 | 1787.88 | 1697.57 | 2382.35 | | | | | | | Raw Materials | 1044.57 | 987.26 | 1106.41 | 894.84 | 924.35 | 799.04 | Power & Fuel Cost | 45.54 | 43.76 | 45.82 | 44.53 | 39.77 | 33.08 | Employee Cost | 267.01 | 272.09 | 272.72 | 230.23 | 223.21 | 224.54 | Other Manufacturing Expenses | 130.03 | 151.87 | 134.86 | 117.43 | 76.00 | 94.37 | Selling & Administrative Expenses | 182.64 | 260.83 | 171.51 | 117.95 | 132.91 | 118.12 | Miscellaneous Expenses | 80.19 | 72.31 | 84.56 | 85.37 | 55.24 | 54.16 | Less : Pre-operative Expenses Capitalised | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Total Expenditure | 1749.98 | 1788.12 | 1815.87 | 1490.35 | 1451.48 | 1323.30 | Operating Profit | 167.54 | 200.11 | 276.32 | 297.53 | 246.08 | 1059.05 | Interest | 138.68 | 74.24 | 65.34 | 66.84 | 54.09 | 81.97 | Gross Profit | 28.86 | 125.87 | 210.98 | 230.69 | 191.99 | 977.08 | Depreciation | 93.62 | 104.37 | 99.34 | 94.24 | 83.00 | 77.81 | Profit Before Tax | -64.76 | 21.50 | 111.64 | 136.45 | 108.99 | 899.27 | Tax | -49.84 | -169.66 | 33.65 | 18.76 | 0.58 | 37.32 | Fringe Benefit tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Deferred Tax | -19.60 | 10.98 | -0.26 | -2.59 | -1.96 | -29.64 | Reported Net Profit | 4.68 | 180.19 | 78.24 | 120.28 | 110.37 | 891.59 | Extraordinary Items | -16.32 | 4.23 | 3.26 | 3.41 | 3.86 | -29.94 | Adjusted Net Profit | 21.00 | 175.96 | 74.98 | 116.87 | 106.51 | 921.53 | Adjustment below Net Profit | 0.00 | 0.00 | 0.00 | -57.25 | -9.30 | -711.39 | P & L Balance brought forward | 740.89 | 583.13 | 522.80 | 616.08 | 532.93 | 393.00 | Statutory Appropriations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Appropriations | 0.00 | 22.43 | 17.91 | 156.30 | 17.91 | 40.27 | P & L Balance carried down | 745.57 | 740.89 | 583.13 | 522.80 | 616.08 | 532.93 | Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 17.90 | Preference Dividend | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Equity Dividend % | 15.00 | 0.00 | 25.00 | 140.00 | 30.00 | 20.00 | Dividend Per Share(Rs) | 1.50 | 0.00 | 2.50 | 14.00 | 3.00 | 2.00 | Earnings Per Share-Unit Curr | 0.52 | 20.07 | 8.72 | 13.43 | 12.32 | 99.62 | Earnings Per Share(Adj)-Unit Curr | 0.52 | 20.07 | 8.72 | 13.43 | 12.32 | 96.41 | Book Value-Unit Curr | 382.61 | 379.36 | 362.18 | 352.68 | 363.69 | 353.28 | Book Value(Adj)-Unit Curr | 382.61 | 379.36 | 362.18 | 352.68 | 363.69 | 341.90 |
|
|
|
|
|
|